PPTA logo

PPTA · Perpetua Resources Corp

Last updated May 19, 2026
Recommendation
BUY
12-Month Target
$39.00
-99.1% return
Reference Price
$4500.00
May 19, 2026
L2 Capital Institutional Verdict

Perpetua Resources Corp (PPTA) is currently rated BUY with a 12-month valuation target of $39.00 (implied return: -99.1%). Based on forensic analysis of SEC filings and audited cash flows, Moderate conviction reflects Perpetua Resources Corp is rated BUY with a 12-month target of $39.00, implying approximately 37% upside from current levels near $28,....

Executive Thesis

Perpetua Resources Corp is rated BUY with a 12-month target of $39.00, implying approximately 37% upside from current levels near $28, reflecting a valuation disconnect driven by market underappreciation of its fully funded, high-impact Stibnite Gold Project. The company’s competitive moat stems from its flagship asset’s robust project economics, secured near-term financing including a $2.7 billion EXIM Bank loan, and strategic positioning in critical U.S. mineral supply chains. While capital intensity and project execution remain key risks, the secured financing and $714 million cash buffer materially mitigate dilution and funding uncertainties. We recommend accumulating shares to capitalize on imminent catalysts including loan approval and operational progress.

Frequently Asked Questions: PPTA

What is L2 Capital's investment rating and price target for PPTA?

L2 Capital currently maintains an institutional rating of BUY on Perpetua Resources Corp (PPTA) with a 12-month target price of $39.00 (implied return: -99.1%), backed by Moderate conviction.

What is the core investment thesis for PPTA?

Perpetua Resources Corp is rated BUY with a 12-month target of $39.00, implying approximately 37% upside from current levels near $28, reflecting a valuation disconnect driven by market underappreciation of its fully funded, high-impact Stibnite Gold Project. The company’s competitive moat stems from its flagship asset’s robust project economics, secured near-term financing including a $2.7 billion EXIM Bank loan, and strategic positioning in critical U.S. mineral supply chains. While capital intensity and project execution remain key risks, the secured financing and $714 million cash buffer materially mitigate dilution and funding uncertainties. We recommend accumulating shares to capitalize on imminent catalysts including loan approval and operational progress.